-+ 0.00%
-+ 0.00%
-+ 0.00%

BullFrog AI signs feasibility pact with top 5 pharma on depression drug targets

PUBT·04/13/2026 11:32:34
Listen to the news
BullFrog AI signs feasibility pact with top 5 pharma on depression drug targets
  • BullFrog AI signed a commercial feasibility agreement on March 30, 2026 with a top 5 global pharmaceutical company by 2025 revenue.
  • bfLEAP platform will be used to identify and prioritize novel drug targets in major depressive disorder.
  • Agreement includes milestone payments tied to defined deliverables.
  • Partner holds an option to secure exclusive rights to a final selected target candidate for research and development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BullFrog AI Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604130730PRIMZONEFULLFEED9688161) on April 13, 2026, and is solely responsible for the information contained therein.